Tranche Update on Caregen Co., Ltd.'s Equity Buyback Plan announced on November 6, 2018.
November 20, 2018 at 08:33 am IST
Share
From November 6, 2018 to November 20, 2018, the company has repurchased 80,000 shares, representing 0.78% for KRW 6,185.55 million. With this, the company has completed the repurchase of 80,000 shares, representing 0.78% for KRW 6,185.55 million under the buyback announced on November 6, 2018.
Caregen Co., LTD is a Korea-based company mainly engaged in the manufacture of cosmeceuticals and dermal fillers. The Company manufactures HSR CEs which used for improving facial wrinkles and strengthening protect wet under the brand name of Dermaheal, aquashines which used for keeping the shin whitening and promoting skin cells activation under the brand name of REVOFIL, HL CEs which used for treating hair loss, hair filler excell C'rums which used for promoting hair growth and preventing hair lose, LL CEs which used for promoting fat decomposition and prevent fat accumulation, hydra B5 Gels, ultra AW500s, eye filler masks, efficacy raw materials including growth facors and biomimetic peptides, and others. The Company distributes its products within domestic market and to overseas markets.
CAREGEN CO., LTD. 